Search Results - "Scipioni, Matteo"
-
1
Structural insights of sulfonamide-based NLRP3 inflammasome inhibitors: design, synthesis, and biological characterization
Published in Medicinal chemistry research (01-02-2021)“…NLRP3 inflammasome has recently attracted much attention as a potentially druggable target to develop potential therapeutics for inflammatory and…”
Get full text
Journal Article -
2
Novel vanillin derivatives: Synthesis, anti-oxidant, DNA and cellular protection properties
Published in European journal of medicinal chemistry (01-01-2018)“…Antioxidants have been the subject of intense research interest mainly due to their beneficial properties associated with human health and wellbeing. Phenolic…”
Get full text
Journal Article -
3
P-23 - Novel vanillin derivatives: An insight into their antioxidant properties
Published in Free radical biology & medicine (20-05-2018)“…Oxidative stress, the unbalance between the occurrence of oxygen/nitrogen reactive species (ROS and RNS) and the ability of the organism to inactivate these…”
Get full text
Journal Article -
4
Novel vanillin derivatives: An insight into their antioxidant properties
Published in Free radical biology & medicine (01-05-2018)Get full text
Journal Article -
5
Synthesis of novel vanillin derivatives: novel multi-targeted scaffold ligands against Alzheimer's disease
Published in MedChemComm (01-05-2019)“…Alzheimer's disease (AD) is the most common cause of dementia worldwide, normally affecting people aged over 65. Due to the multifactorial nature of this…”
Get full text
Journal Article -
6
Synthesis of Novel Vanillin Derivatives : Study of Their Antioxidant and Potential Neuroprotective Properties
Published 01-01-2019“…Vanillin (4-hydroxy-3-methoxybenzaldehyde) is a naturally-occurring phenolic compound, forming the main component of the bean and pod of vanilla orchids. It is…”
Get full text
Dissertation -
7
Synthesis of novel vanillin derivatives: novel multi-targeted scaffold ligands against Alzheimer's disease† †Electronic supplementary information (ESI) available. See DOI: 10.1039/c9md00048h
Published in MedChemComm (08-04-2019)“…Novel vanillin–tacrine hybrid acting as AChE and Aβ (1–42) amyloid aggregation inhibitor with strong antioxidant properties enhanced by the p -phenylenediamine…”
Get full text
Journal Article